[{"Assets_0_Q2_USD":724244000.0,"CommonStockSharesOutstanding_0_Q2_shares":77038788.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-122951000.0,"NetIncomeLoss_1_Q2_USD":-76437000.0,"NetIncomeLoss_2_Q2_USD":-144961000.0,"StockholdersEquity_0_Q2_USD":370641000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":76767000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":76693000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":76767000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":76693000.0,"Ticker":"INSM","CIK":"1104506","name":"INSMED INC","OfficialName":"Insmed Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2980602494.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180802"}]